Affiliation:
1. Changi General Hospital
Abstract
Abstract
Septic arthritis (SA) is a rare but potentially debilitating condition that can have quality-of-life impacting consequences. Prompt diagnosis and management is pivotal for early infection eradication and prevention of severe joint destruction. However, in a severely destructed joint, surgical options include resection arthroplasty or total hip arthroplasty (THA). Two-stage THA has been described in native hip SA with joint destruction while 1.5-stage THA has only been described in infected THA. This led to the consideration of 1.5-stage THA for management of chronic destructive hip SA. We report a 67-year-old patient with functional decline over eight months. Work-up revealed raised inflammatory markers and bilateral destructive hip SA. He underwent bilateral 1.5-stage THA with antibiotic-loaded Custom-Made Articulating Spacers (CUMARS). Post-operatively, he remains infection free is progressing well with rehabilitation. Management of SA varies largely depending on infection duration, activity level and extent of joint destruction. In primary destructive hip SA, a 1.5-stage THA with CUMARS can be considered due to the benefits of effective infection eradication, cost-effectiveness with reduced physical and psychological burden in avoiding a second operation, yet not precluding the possibility of a two-stage exchange THA if required.
Publisher
Research Square Platform LLC
Reference25 articles.
1. Bacterial septic arthritis in adults;Mathews CJ;Lancet,2010
2. Acute Pyogenic Arthritis of the Hip: An Operation Giving Free Access and Effective Drainage: GR Girdlestone BM OXFD, FRCS;Brand RA;Clin Orthop Relat Res,2008
3. Excision arthroplasty for infected total hip replacements;McElwaine J;J Bone Joint Surg Br Volume,1984
4. Yan S-g. Total hip arthroplasty for patients with osteoarthritis secondary to hip pyogenic infection;Gao X;Chin Med J,2010
5. Aalirezaie A, Arumugam SS, Austin M, Bozinovski Z, Cichos KH, Fillingham Y et al. Hip and knee section, prevention, risk mitigation: Proceedings of International Consensus on Orthopedic Infections. The Journal of arthroplasty. 2019;34(2):S271-S8.